News

Scientists at the UNC School of Medicine and NC State have created an injectable gel-like scaffold that can hold combination chemo-immunotherapeutic drugs and deliver them locally to tumors in a sequential manner.

A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Amidst growing concerns over the low uptake of flu shots in Europe, scientists from the Italian National Research Council and the JRC confirm that vaccinations remain the best way forward when it comes to stopping the spread of infectious diseases.

A new bioinformatics technique allows researchers to study three key processes inside the cell simultaneously.

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body.

In a world first, scientists have been able to recreate images perceived by test subjects using only data from their EEG scans.

One of the biggest obstacles to eradicating malaria is a dormant form of the parasite which is resistant to most antimalarial drugs and can reawaken years later, causing disease relapse. Researchers have shown they can grow the dormant parasite in engineered human liver tissue for several weeks, allowing them to closely study how the parasite becomes dormant, what vulnerabilities it may have, and how it springs back to life.

DNA is folded into loops by a protein called condensin, and the process has been filmed for the first time.

Tandem mass spectrometry has revealed that Streptomyces chartreusis, an antibiotic-producing bacterium, releases more metabolites into the surrounding medium than scientists assumed based on the analysis of the genome. They might include molecules that are of interest as potential pharmaceutical agents.

The computer model integrates over 4,000 metabolites and 13,000 proteins.